"Asthma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Descriptor ID |
D001249
|
| MeSH Number(s) |
C08.127.108 C08.381.495.108 C08.674.095 C20.543.480.680.095
|
| Concept/Terms |
Asthma- Asthma
- Asthmas
- Bronchial Asthma
- Asthma, Bronchial
|
Below are MeSH descriptors whose meaning is more general than "Asthma".
Below are MeSH descriptors whose meaning is more specific than "Asthma".
This graph shows the total number of publications written about "Asthma" by people in this website by year, and whether "Asthma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 2 | 1 | 3 |
| 1996 | 3 | 1 | 4 |
| 1997 | 2 | 2 | 4 |
| 1998 | 9 | 0 | 9 |
| 1999 | 3 | 4 | 7 |
| 2000 | 4 | 0 | 4 |
| 2001 | 6 | 1 | 7 |
| 2002 | 11 | 0 | 11 |
| 2003 | 11 | 3 | 14 |
| 2004 | 18 | 2 | 20 |
| 2005 | 13 | 3 | 16 |
| 2006 | 26 | 5 | 31 |
| 2007 | 18 | 4 | 22 |
| 2008 | 16 | 3 | 19 |
| 2009 | 19 | 2 | 21 |
| 2010 | 20 | 3 | 23 |
| 2011 | 17 | 4 | 21 |
| 2012 | 16 | 3 | 19 |
| 2013 | 25 | 4 | 29 |
| 2014 | 29 | 3 | 32 |
| 2015 | 21 | 8 | 29 |
| 2016 | 33 | 5 | 38 |
| 2017 | 24 | 4 | 28 |
| 2018 | 29 | 3 | 32 |
| 2019 | 35 | 9 | 44 |
| 2020 | 36 | 2 | 38 |
| 2021 | 27 | 1 | 28 |
| 2022 | 31 | 0 | 31 |
| 2023 | 35 | 0 | 35 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Asthma" by people in Profiles.
-
Analytical challenges in omics research on asthma and allergy: A?National Institute of Allergy and Infectious Diseases workshop. J Allergy Clin Immunol. 2024 Apr; 153(4):954-968.
-
Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma. Respir Med. 2024 Mar; 223:107537.
-
Portable Air Purifiers to Mitigate the Harms of Wildfire Smoke for People with Asthma. Am J Respir Crit Care Med. 2024 Jan 15; 209(2):126-128.
-
Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders. Chest. 2024 Apr; 165(4):775-784.
-
Improving food allergy management: Control asthma and decrease food allergy risk. Ann Allergy Asthma Immunol. 2024 Mar; 132(3):265-266.
-
Influence of baseline bronchodilator reversibility and blood eosinophils on lung function in patients with asthma following omalizumab. J Allergy Clin Immunol Pract. 2024 02; 12(2):512-514.e2.
-
CC16 drives VLA-2-dependent SPLUNC1 expression. Front Immunol. 2023; 14:1277582.
-
Adding tiotropium or long-acting ?2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization. Allergy Asthma Proc. 2023 11 13; 44(6):413-421.
-
Update on the Role of Fungus in Allergy, Asthma, and the Unified Airway. Otolaryngol Clin North Am. 2024 Apr; 57(2):279-292.
-
Early Administration of Steroids in the Ambulance Setting: An?Observational Design Trial (EASI-AS-ODT). Acad Emerg Med. 2024 Jan; 31(1):49-60.